TG8-260
TG8-260 is a potent and orally bioavailable EP2 receptor antagonist developed for research on neuroinflammatory and peripheral inflammatory diseases. It demonstrates efficacy in reducing gliosis and inflammation in rodent seizure models and inhibits pro-inflammatory gene expression in microglial cell assays, supporting its use in both in vivo and in vitro anti-inflammatory pathway studies.
Product Specifications
CAS Number
2490544-50-6
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
98.02% (May vary between batches)
Smiles
O=C (NCCC=1C=2C=CC=CC2NC1C) C=3C=CC (=CC3) C4=CN=CN4
Molecular Formula
C21H20N4O
Molecular Weight
344.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AF2088-SP 25 µg
Human Langerin/CD207 Affinity Purified Polyclonal Ab
Sign In for Pricing
View Details MBS6401539-01 0.1 mL
OASIS (Cyclic AMP-responsive Element-binding Protein 3-like Protein 1, cAMP-responsive Element-binding Protein 3-like Protein 1, Old Astrocyte Specifically-induced Substance, Processed Cyclic AMP-responsive Element-binding Protein 3-like Protein 1, CREB3L
Sign In for Pricing
View Details MBS6401539-02 5x 0.1 mL
OASIS (Cyclic AMP-responsive Element-binding Protein 3-like Protein 1, cAMP-responsive Element-binding Protein 3-like Protein 1, Old Astrocyte Specifically-induced Substance, Processed Cyclic AMP-responsive Element-binding Protein 3-like Protein 1, CREB3L
Sign In for Pricing
View Details 
E45H35658M5 20 µg
GIPC (GIPC1) (NM_005716) Human Recombinant Protein
Sign In for Pricing
View Details 
K6706402 1.0 µg DNA
Arhgap4 sgRNA CRISPR Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details